A Cyclic Hexapeptide Is a Potent Antagonist of α4 Integrins

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1710-1718

  Vanderslice, Peter ^a,c   Ren, Kaijun ^b   Revelle, Joanna K ^a   Kim, David C ^a   Scott, Dee ^a   Bjercke, Robert J ^a   Yeh, Edward T H ^a   Beck, Pamela J ^a   Kogan, Timothy P ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c TEXAS BIOTECHNOLOGY CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CS1 PEPTIDE; CYCLOPEPTIDE; FIBRONECTIN; IMMUNOGLOBULIN; INTEGRIN; MADCAM1 PROTEIN, HUMAN; MUCOPROTEIN; OLIGOPEPTIDE; PEPTIDE; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING COMPETITION; CELL ADHESION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING; RABBIT;

AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CELL ADHESION; FEMALE; FIBRONECTINS; HUMANS; IMMUNOGLOBULINS; INTEGRINS; MOLECULAR SEQUENCE DATA; MUCOPROTEINS; OLIGOPEPTIDES; PEPTIDES; PEPTIDES, CYCLIC; PROTEIN BINDING; RABBITS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031568396     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11.
2. Hemler, M. E., C. Huang, Y. Takada, L. Scharz, J. L. Strominger, and M. L. Clabby. 1987. Characterization of the cell surface heterodimer VLA-4 and related peptides. J. Biol. Chem. 262:11478.
3. Bochner, B.S., F. W. Luscinskas, M. A. Gimbrone, W. Newman, S. A. Sterbinsky, C. P. Derse-Anthony, D. Klunk, and R. P. Schleimer. 1991. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cell: contributions of endothelial cell adhesion molecules. J. Exp. Med. 173:1553.
4. 1. J. Biol. Chem. 267:14019.
5. Rosen, G. D., J. R. Sanes, R. LaChance, J. M. Cunningham, J. Roman, and D. C. Dean. 1992. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell 69:1107.
6. 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1. Cell Regul. 2:347.
7. Elices, M. J., L. Osborn, Y. Takada, C. Crouse, S. Luhowskyj, M. E. Hemler, and R. R. Lobb. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integin VLA-4/fibronectin binding site. Cell 69:577.
8. Wayner, E. A., A. Garcia-Pardo, M. J. Humpheries, J. A. McDonald, and W. G. Carter. 1989. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol. 109:1321.
9. 7, on human leukocytes. J. Immunol. 153:517.
10. 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:85.
11. p in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering. J. Cell Biol. 117:179.
12. 1. J. Exp. Med. 182:345.
13. Masumoto, A., and M. E. Hemler. 1993. Multiple activation states of VLA-4. J. Biol. Chem. 268:228.
14. 1 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand. J. Biol. Chem. 270:28740.
15. Issekutz, T. B. 1991. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissue by the TA-2 monoclonal antibody. J. Immunol. 147:4178.
16. Chuluyan, H. E., and A. C. Issekutz. 1993. VLA-4 integrin can mediate CD11/ CD18-independent transendothelial migration of human monocytes. J. Clin. Invest. 92:2768.
17. 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413.
18. 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J. Clin. Invest. 93:776.
19. 1 integrin. Nature 356:63.
20. 4-integrins and vascular cell adhesion molecule-1. J. Clin. Invest. 93:1700.
21. Burkly, L. C., A. Jakubowski, and M. Hattori. 1994. Protection against adoptive transfer of autoimmune diabetes mediated through very late antigen-4 integrin. Diabetes 43:529.
22. 4 integrin monoclonal antibody. J. Clin. Invest. 92:372.
23. Lazarovits, A. I., R. A. Moscicki, J. T. Kurnick, D. Camerini, A. K. Bhan, L. G. Baird, M. Erikson, and R. B. Colvin. 1984. Lymphocyte activation antigens: a monoclonal antibody, anti-act I, defines a new late lymphocyte activation antigen. J Immunol. 133:1857.
24. Misra, D. N., S. A. Noesman, H. W. Knuz, and T. J. Gill. 1986. Growth of rat-mouse hybridomas in nude mice and nude rats. Methods Enzymol. 121:386.
25. Bjercke, R. J., C. C. Stephan, D. A. Erichsen, R. E. Martinez, S. Sherwood, R. Owens, and T. A. Brock. 1995. Chronic therapy with bFGF antibody reduces balloon injury-induced intimal thickening in rat carotid artery. FASEB J. 9:A343.
26. Butcher, E. C., R. G., Scollay and I. L. Weissman. 1980. Organ specificity of lymphocyte migration: mediation by highly selective lymphocyte interaction with organ-specific determinants on high endothelial venules. Eur. J. Immunol. 10:556.
27. Boyun, A. 1968. Isolation of mononuclear cells and granulocytes from human blood Scand. J. Clin. Lab. Invest. 21(Suppl. 97):77.
28. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor.
29. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463.
30. Osborn, L., C. Hession, R. Tizard, C. Vassallo, S. Luhowskyj, G. Chi-Rosso, and R. Lobb. 1989. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59:1203.
31. Kogan, T. P., B. M. Revelle, S. Tapp, D. Scott, and P. J. Beck. 1995. A single amino acid residue can determine the ligand specificity of E-selectin. J. Biol. Chem. 270:14047.
32. Kunkel, T. A., J. D. Roberts, and R. A. Zabour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367.
33. Briskin, M. J., L. M. McEvoy, and E. C. Butcher. 1993. MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature 363:461.
34. Morrison, M. 1974. The determination of exposed proteins on membranes by the use of lactoperoxidase. Methods Enzymol. 32:103.
35. 1. J. Biol. Chem. 265:4020.
36. 1. J. Biol. Chem. 267:25274.
37. Jones, E. Y., K. Harlos, M. J. Bottomley, R. C. Robinson, P. C. Driscoll, R. M. Edwards, J. M. Clements, T. J. Dudgeon, and D. I. Stuart. 1995. Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 A resolution. Nature 373:539.
38. 1) J. Cell Biol. 124:601.
39. Vonderheide, R. H., T. F. Tedder, T. A. Springer, and D. E. Staunton. 1994. Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4. J. Cell Biol. 125:215.
40. Clements, J. M., P. Newham, M. Shepherd, R. Gilbert, T. J. Dudgeon, L. A. Needham, R. M. Edwards, L. Berry, A. Brass, and M. J. Humphries. 1994. Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin. J. Cell Sci. 107:2127.
41. + memory T cells with hallmarks of gut-trophism. J. Immunol. 151:717.
42. Wayner, E. A., and N. L. Kovach. 1992. Activation-dependent recognition by hematopoietic cells of the LDV sequence in the V region of fibronectin. J. Cell Biol. 116:489.
43. Hemler, M. E., M. J. Elices, C. Parker, and Y. Takada. 1990. Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol. Rev. 114:45.
44. 1 integrin through the β1 subunit induces recognition of the RGDS sequence in fibronectin. J. Cell Biol. 126:271.
45. 1 integrin-mediated cell adhesion. J. Biol. Chem. 268:20352.
46. 1 interaction with connecting segment 1 and vascular cell adhesion molecule. J. Biol. Chem. 269:18668.
47. 1: regulation of the functional response by soluble fibronectin. J. Cell Biol. 121:155.
48. Cabanas, C., and N. Hogg. 1993. Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1. Proc. Natl. Acad. Sci. USA 90:5838.
49. 4 integrin interaction. Proc. Natl. Acad. Sci. USA 92:5714.
50. 7. J. Immunol. 156:719.
51. Chisholm, P. L., C. A. Williams, and R. R. Lobb. 1993. Monoclonal antibodies to the integrin α-4 subunit inhibit the murine contact hypersensitivity response. Eur. J. Immunol. 23:682.
52. Isobe, M., J. Suzuki, H. Yagita, K. Okumura, S. Yamazaki, R. Nagai, Y. Yazaki, and M. Sekiguchi. 1994. Immunosuppression to cardiac allografts and soluble antigens by anti-VCAM-1 and anti-VLA-4 monoclonal antibodies. J. Immunol. 153:5810.
53. Ferguson, T. A., H. Mitzutani, and T. S. Kupper. 1991. Two integrin-binding peptides abrogate T cell-mediated immune responses in vivo. Proc. Natl. Acad. Sci. USA 88:8072.
54. Wahl, S. M., J. B. Allen, K. L. Hines, T. Imamichi, A. M. Wahl, L. T. Furcht, and J. B. McCarthy. 1994. Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J. Clin. Invest. 94:655.
55. Molossi, S., M. Elices, T. Arrhenius, R. Diaz, C. Coulber, and M. Rabinovitch. 1995. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J. Clin. Invest. 95:2601.